TopFind

AI Summary

We reviewed 2077 live results for special access programs and narrowed them down to the 3 options that look most worth comparing first.

The strongest themes across this short list are Pharmaceutical Services and Healthcare Distribution.

Comparison Table

Recommended

Special Access Route (SAR) Glucagon Access

Source: Eli Lilly (Singapore) Pte Ltd

Description

Access to unregistered therapeutic products like Baqsimi in the Singapore market is managed through the Special Access Route (SAR) or Named Patient basis. This service involves physician-led requests for medications not currently listed on the standard Health Sciences Authority (HSA) retail market.

Best for

Singapore medical practitioners, patients with specific medical needs and unregistered drug import support

View Details

Rating

Access PeopleHR

Source: The Access Group

Description

A comprehensive cloud HR software solution including core employee records, recruitment applicant tracking (ATS), performance management, expense tracking, and 'Ripple' workflow automation for global teams. The platform provides a centralized hub for managing human capital with scalable tools for growing organizations.

Best for

small to mid-sized businesses, global HR management, recruitment tracking and workflow automation

View Details

Rating

Special Omakase

Source: Sushi Oribe

Description

The Special Omakase is Sushi Oribe's premier offering, requiring advance notice of 2 to 7 days for a highly personalized and curated seafood experience. The menu features elite seasonal selections and authentic Japanese preparation styles that highlight the freshness of the ingredients.

Best for

exclusive dining, advanced bookings, personalized meals and urban foodies

View Details

Rating

AI Recommendation

If you want the most balanced option to start with, I recommend:

"Special Access Route (SAR) Glucagon Access from Eli Lilly (Singapore) Pte Ltd."

I picked this because Eli Lilly is a key local contact for diabetes care in Singapore and can provide guidance on specialized access for their therapeutic portfolio.

Share this search

Related Finds